|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-4-6
|
|
pubmed:abstractText |
Ferumoxytol, an iron oxide nanoparticle that targets phagocytic cells, can be used in magnetic resonance imaging of malignant brain tumors and can be administered as a bolus, allowing dynamic imaging. Our objectives were to determine the optimum time of delayed contrast enhancement of ferumoxytol, and to compare ferumoxytol and gadolinium contrast agents for magnetic resonance angiography and perfusion.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4040
|
|
pubmed:author |
pubmed-author:HaluskaMarianneM,
pubmed-author:HoffmanJohn MJM,
pubmed-author:HuntMatthew AMA,
pubmed-author:JacobsPaula MPM,
pubmed-author:Jerosch-HeroldMichaelM,
pubmed-author:ManningerSándorS,
pubmed-author:NesbitGaryG,
pubmed-author:NeuweltEdward AEA,
pubmed-author:SolymosiDiánaD,
pubmed-author:StevensAlexanderA,
pubmed-author:VárallyayCsanád GCG
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
601-11; discussion 611-2
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17415196-Adult,
pubmed-meshheading:17415196-Aged,
pubmed-meshheading:17415196-Brain Neoplasms,
pubmed-meshheading:17415196-Contrast Media,
pubmed-meshheading:17415196-Feasibility Studies,
pubmed-meshheading:17415196-Female,
pubmed-meshheading:17415196-Ferumoxytol,
pubmed-meshheading:17415196-Gadolinium DTPA,
pubmed-meshheading:17415196-Humans,
pubmed-meshheading:17415196-Image Enhancement,
pubmed-meshheading:17415196-Magnetic Resonance Angiography,
pubmed-meshheading:17415196-Male,
pubmed-meshheading:17415196-Middle Aged,
pubmed-meshheading:17415196-Nanoparticles,
pubmed-meshheading:17415196-Perfusion,
pubmed-meshheading:17415196-Pilot Projects
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
|
|
pubmed:affiliation |
Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA. neuwelte@ohsu.edu
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies,
Research Support, N.I.H., Extramural
|
